Co-Diagnostics announces a breakthrough in rapid diagnostic testing, potentially revolutionizing point-of-care diagnostics. The company's stock sees a surge following the news, with analysts predicting significant market impact.
Co-Diagnostics is a biotechnology company specializing in diagnostic tests.
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing